This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nunes, G. L. Articles by Scott, N. A. Search for Related Content PubMed PubMed Citation Articles by Nunes, G. L. Articles by Scott, N. A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Angioplasty Blood Thinners Hazardous Substances DB HEPARIN TRITIUM

(Circulation. 1995;92:1697-1700.)
© 1995 American Heart Association, Inc.

Articles

Inhibition of Platelet-Dependent Thrombosis by Local Delivery of Heparin With a Hydrogel-Coated Balloon

Gilberto L. Nunes, MD; Clifford N. Thomas, MD; Stephen R. Hanson, PhD; James J. Barry, PhD; Spencer B. King, III, MD; Neal A. Scott, MD, PhD

From the Andreas R. Gruentzig Cardiovascular Center (G.L.N., C.N.T., S.B.K. III, N.A.S.) and the Division of Hematology-Oncology (S.R.H.), Emory University Hospital, Atlanta, Ga; and Boston Scientific Corp (J.J.B.), Watertown, Mass.

Correspondence to Neal A. Scott, MD, PhD, Andreas R. Gruentzig Cardiovascular Center, Emory University Hospital, F-606, 1364 Clifton Rd, Atlanta, GA 30322.

Background Systemic administration of heparin can decrease mortality and morbidity of acute ischemic coronary syndromes such as unstable angina and myocardial infarction. Hemorrhage is the major limiting factor in the clinical use of systemic heparin. The objective of the present study was to determine whether local delivery of heparin could inhibit platelet-dependent thrombosis without altering systemic bleeding parameters.

Methods and Results Hydrogel-coated angioplasty balloon catheters were dipped in a heparin solution, dried, and applied to a platelet-rich mural thrombus in a chronic ex vivo porcine arteriovenous shunt. ¹¹¹In-labeled platelet deposition was quantified by gamma camera imaging. In a separate series of experiments, ³H-heparin was used to estimate the amount of heparin delivered to the thrombus with the coated balloon. Systemic heparin administration produced a dose-dependent decrease in platelet-dependent thrombus formation that was maximal at 200 units/kg. Bleeding times and activated partial thromboplastin times were prolonged at this dose. An equal inhibition of thrombus formation was achieved after the coated balloon was dipped in a heparin solution (10 000 units/mL) and deployed at the mural thrombus. In contrast to systemic heparin administration, there was no alteration in bleeding parameters associated with local heparin delivery. The estimated amount of heparin delivered with the coated balloon was 40 units.

Conclusions Local delivery of heparin in amounts sufficient to inhibit platelet-dependent thrombosis can be accomplished with a hydrogel-coated coronary angioplasty balloon catheter. Local heparin delivery can inhibit thrombus formation in amounts that are several orders of magnitude lower than the required systemic dose. Local delivery of heparin was not associated with prolongation of bleeding parameters.

Key Words: thrombosis • heparin

This article has been cited by other articles:

				M. Kalinowski, H. Alfke, S. Bergen, K. J. Klose, J. J. Barry, and H.-J. Wagner Comparative Trial of Local Pharmacotherapy with L-Arginine, r-Hirudin, and Molsidomine to Reduce Restenosis after Balloon Angioplasty of Stenotic Rabbit Iliac Arteries Radiology, June 1, 2001; 219(3): 716 - 723. [Abstract] [Full Text] [PDF]

				K. G. Lehmann, J. J. Popma, J. A. Werner, A. J. Lansky, and R. L. Wilensky Vascular remodeling and the local delivery of cytochalasin B after coronary angioplasty in humans J. Am. Coll. Cardiol., March 1, 2000; 35(3): 583 - 591. [Abstract] [Full Text] [PDF]

				S. Kaul, R. R. Makkar, M. Nakamura, F. I. Litvack, P. K. Shah, J. S. Forrester, T. C. Hutsell, and N. L. Eigler Inhibition of Acute Stent Thrombosis Under High-Shear Flow Conditions by a Nitric Oxide Donor, DMHD/NO: An Ex Vivo Porcine Arteriovenous Shunt Study Circulation, November 1, 1996; 94(9): 2228 - 2234. [Abstract] [Full Text]